Literature DB >> 32265017

Thromboembolic events in inflammatory bowel disease.

S Mrabet1, N Elleuch2, A Ben Slama2, H Jaziri2, A Hammami2, A Braham2, S Ajmi2, M Ksiaa2, A Jmaa2.   

Abstract

GOAL OF THE STUDY: Inflammatory bowel disease (IBD) is associated with an increased risk of thromboembolic events (TEE) during outbreaks, increasing morbidity and mortality. The aim of our study was to specify the prevalence of TEE in IBD patients and to determine their epidemiological, clinical and evolutionary characteristics. MATERIEL AND METHODS: This is a retrospective study collecting all patients with IBD, who had a thromboembolic complication confirmed by imagery, between January 2012 and December 2018.
RESULTS: One hundred patients with IBD were diagnosed during the study period. A TEE occurred in 6 patients (5.9%). These patients had an average age of 41 years, divided into 4 women and 2 men. Five patients had Crohn's disease and one patient had ulcerative colitis. The IBD was active in all patients. Five patients were already hospitalized and under preventive heparin therapy. Patients had deep venous thrombosis of the lower limbs in 3 cases, associated with pulmonary embolism in 1 case, cerebral venous thrombosis in 2 cases and pulmonary embolism isolated in 1 case. Thrombophilia investigations were negative in all patients. Evolution under medical treatment was favorable in 4 patients and fatal in 2 patients.
CONCLUSION: In our study, the prevalence of TEE in patients with IBD was 5.9%. Thrombosis occurred during the active phase of IBD in all cases.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Embolism; Inflammatory bowel disease; Thrombosis

Mesh:

Substances:

Year:  2020        PMID: 32265017     DOI: 10.1016/j.jdmv.2020.01.148

Source DB:  PubMed          Journal:  J Med Vasc        ISSN: 2542-4513


  1 in total

1.  The Demographic Data and Prevalence of Thromboembolic Events Among Inflammatory Bowel Disease Patients in Buraydah, Al-Qassim Region.

Authors:  Arwa A Alodheilah; Omar A Alnujeidi; Nada A AlDhuwayhi; Maha M AlDhilan; Fatimah S Alsultan; Majd I Aldhuwayhi; Haya S Alnumayr; Fai M AlHotan; Shatha E Aljamaan
Journal:  Cureus       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.